Benefits and risks of Covid-19 vaccines: rapid authorisations are possible, but premature vaccinations are not the answer for Switzerland
Bern, 11.12.2020 - The safety of the Swiss population has top priority The regulatory authority in the United States, the FDA, will shortly decide on an emergency approval (Emergency Use Authorisation) for the use of the coronavirus vaccine from Pfizer/BioNTech. An emergency approval for vaccines is not a legal option in Switzerland. Swissmedic works closely with international partner authorities and reviews all applications for COVID-19 vaccines as a matter of urgency and in a “rolling” procedure. The companies supplied further details on their COVID-19 vaccines. This enables authorisations to be issued quickly once sufficient data on safety, efficacy and quality are available.